A comparative analysis of biologics market dynamics in 12 countries: (Bio)similar and sustainability
The introduction of biosimilars was significantly associated with reductions in the prices and expenditures of biologics in high-income countries. This underscores the potential role of biosimilars in supporting the long-term sustainability of the healthcare system.
Authors
- Gyeongseon Shin
- SeungJin Bae (ORCID: https://orcid.org/0000-0002-8993-8884)
- Euna Han (ORCID: https://orcid.org/0000-0003-2656-7059)
- Huang‐Tz Ou (ORCID: https://orcid.org/0000-0002-5475-7848)
- Gyeyoung Choi (ORCID: https://orcid.org/0000-0002-9679-8779)
- Yifan Song (ORCID: https://orcid.org/0000-0003-0565-6271)
Institutions
- Ewha Womans University (KR)
- Yonsei University (KR)
- Wonkwang University (KR)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-11-11
- DOI
- https://doi.org/10.3389/fphar.2025.1659395
- Primary Topic
- Biosimilars and Bioanalytical Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Food and Drug Safety